Abbott Labs and Reckitt Benckiser shares surge on court’s baby formula ruling

by | Nov 1, 2024 | Stock Market

A court in St. Louis, Missouri ruled in favor of Abbott Laboratories and Reckitt Benckiser over claims their specialized baby formula caused users to develop a bowel disease called NEC

Article Attribution | Read More at Article Source